Related Experiment Videos
NCCN Guidelines Insights: Breast Cancer, Version 1.2017.
William J Gradishar1, Benjamin O Anderson2, Ron Balassanian3
1Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Journal of the National Comprehensive Cancer Network : JNCCN
|April 14, 2017
Summary
The National Comprehensive Cancer Network (NCCN) updated breast cancer guidelines in 2017, focusing on surgical axillary staging, radiation therapy, and systemic therapy for hormone receptor-positive disease.
Area of Science:
- Oncology
- Clinical Guidelines
Background:
- The NCCN Guidelines for Breast Cancer provide evidence-based recommendations for cancer care.
- Regular updates are crucial to incorporate the latest research and treatment advancements.
Purpose of the Study:
- To summarize key updates in the 2017 version of the NCCN Guidelines for Breast Cancer.
- To discuss the rationale behind changes in surgical axillary staging, radiation therapy, and systemic therapy for hormone receptor-positive breast cancer.
Main Methods:
- Review of the NCCN Guidelines for Breast Cancer version 1.2017.
- Analysis of changes related to surgical axillary staging, radiation therapy, and systemic therapy.
- Discussion of the supporting evidence and clinical rationale for the updates.
Main Results:
- Significant updates were made to recommendations for surgical axillary staging.
- Changes were introduced in radiation therapy protocols.
- Revised systemic therapy recommendations were provided for hormone receptor-positive breast cancer.
Conclusions:
- The 2017 NCCN Guidelines for Breast Cancer reflect important advancements in treatment strategies.
- These updates aim to optimize patient outcomes through refined staging, radiation, and systemic therapy approaches.
- Physicians should consult the latest NCCN guidelines for the most current treatment information.